baber/WOPTO huggingface dataset:
Patent AT-E354577-T1 (AT)
Inventor: ANGEHRN PETER
IPC: C07D501/04
Filed: 1997-10-29
Granted: 2007-03-15
Abstract: The present invention relates to cephalosporin derivatives of the general formula <CHEM>  where   R<1>   is halogen, lower alkyl, phenyl, benzyl, styryl, naphthyl or heterocyclyl; the lower alkyl, phenyl, benzyl, styryl, naphthyl and heterocyclyl being optionally substituted by at least one of halogen, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkoxy, optionally substituted phenyl, amino, lower alkylamino, di-lower alkylamino, carboxy, lower alkylcarboxy, carbamoyl or lower alkylcarbamoyl; R<4>, R<5>   independently are hydrogen, lower alkyl or phenyl; X   is S, O, NH or CH2; n   is 0,1 or 2; m   is 0 or 1; s   is 0 or 1; R<2>   is hydrogen, hydroxy, -CH2-CONHR<6>, lower alkyl-Qr, cycloalkyl-Qr, lower alkoxy, lower alkenyl, cycloalkenyl-Qr, lower alkynyl, aralkyl-Qr, aryl-Qr, aryloxy, aralkoxy, a heterocyclic ring or a heterocyclyl-Qr, the lower alkyl, cycloalkyl, lower alkoxy, lower alkenyl, cycloalkenyl, lower alkynyl, aralkyl, aryl, aryloxy, aralkoxy and the heterocyclic ring may be substituted with at least one group selected from carboxy, amino, nitro, cyano, -SO2NHR<6>, optionally fluoro substituted lower alkyl, lower alkoxy, hydroxy, halogen, -CONR<6>R<7>, -CH2CONR<6>R<7>, -N(R<7>)COOR<8>, R<7>CO-, R<7>OCO-, R<7>COO-, -C(R<7>R<9>)CO2R<8>, -C(R<7>R<9>)CONR<7>R<10>, wherein     R<6> is hydrogen, lower alkyl, cycloalkyl or aryl;   R<7> and R<9> are independently hydrogen or lower alkyl; R<8> is hydrogen, lower alkyl, lower alkenyl or a carboxylic acid protecting group; and R<10> is hydrogen,  omega -hydroxy-alkyl, phenyl, naphthyl or heterocyclyl, the phenyl, naphthyl or heterocyclyl being unsubstituted or substituted with at least one of the groups of optionally protected hydroxy, halogen, optionally substituted lower alkyl or  omega -hydroxyalkyl, optionally substituted lower alkoxy and/or cyano, or R<7> and R<10> form together group of formula <CHEM>     Q   is -CHR-, -CO- or -SO2-; r   is 0 or 1; R   is hydrogen or lower alkyl; and R<3>   is hydroxy, -O<->, lower-alkoxy, or -OM and M represents an alkali metal; as well as readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts, as wen as the preparation of such compounds, their use for the treatment of infectious diseases and pharmaceutical preparations containing such compounds.
Patent AT-E280706-T1 (AT)
Inventor: OYVIND TVEIT
IPC: B63B13/00
Filed: 1992-11-02
Granted: 2004-11-15
Abstract: A liquid residue (14) is drained from the bottom (10a) of a tank (10) via a drain pipe (15) having its open bottom intake end (13a) near the tank bottom, using a pump or ejector (16) arranged at a level substantially above the upper level of the liquid residue (14). The pump (16) or ejector establishes an upwardly directed gas/liquid current in the drain pipe (15). At distinct levels (A1, A2) above the upper surface of the liquid residue, a gas medium is sucked into the drain pipe (15) through gas inlet openings (19a, 19b) in the drain pipe wall in order to mix this gas medium with the gas/liquid current passing through the drain pipe (15).
Patent AT-E278645-T1 (AT)
Inventor: NEIRA POUS JOAN MARIA
IPC: C04B5/06
Filed: 1997-02-14
Granted: 2004-10-15
Abstract: A concrete mix for bulk use or for casting prefabricated parts contains a small amount of portland cement and water together with ground slag and fly-ash from coal-burning electricity generation plant, the slag and ash being of controlled particle size ranges and content. The mixture may also contain sand and/or expanded clay and a foaming agent may be incorporated. It is formed into shape in vibrating moulds or by extrusion and left to dry in air for 24 hours. Where the products are to be subjected to thermal treatment the cement may be replaced by sodium silicate. A pre-mix may be initially prepared from sodium silicate slag and ash and granulated, the granules being hardened in an oven before being mixed with cement and further ash and slag.
Patent AT-E226450-T1 (AT)
Inventor: GURNY ROBERT
IPC: A61K9/20
Filed: 1997-02-26
Granted: 2002-11-15
Abstract: A pharmaceutical composition for the controlled release of therapeutic agents from carboxylic acid ortho ester polymers contains a pharmaceutically acceptable salt of an acid, which together with the acid R1-COOH liberated from the decomposition of the ortho ester polymer forms a buffer system in a physiologically acceptable pH range.
Patent AT-E290210-T1 (AT)
Inventor: GOLBUS MITCHELL
IPC: G01N33/53
Filed: 1997-10-20
Granted: 2005-03-15
Abstract: An in vitro method of identifying or isolating fetal cells from a blood sample is described. Fetal nucleated erythrocytes or erythroblasts are identified by using an antibody or antibody fragment specific for embryonic hemoglobin or an embryonic hemoglobin chain. Once the fetal cells are identified, they can be treated to render the fetal nucleic acids or proteins available for identification or amplification. Detecting the occurrence or existence of selected fetal nucleic acids or proteins allows a quantitative or qualitative diagnostic or prenatal evaluation, including determining the sex of the fetus, determining chromosomal, single gene or protein abnormalities, and determining the presence or absence of particular genes, nucleic acid sequences or proteins.
Patent AT-E279532-T1 (AT)
Inventor: NAKAMURA MITSUHIRO
IPC: C12Q1/60
Filed: 1997-04-10
Granted: 2004-10-15
Abstract: A method for quantitatively determining LDL cholesterol, including the steps of adding to serum a surfactant selected from among polyoxyethylenealkylene phenyl ethers and polyoxyethylenealkylene tribenzylphenyl ethers and a cholesterol-assaying enzyme reagent so as to preferentially react cholestrols in high density- and very low density-cholesterols among lipoproteins, and subsequently determining the amount of cholesterol that reacts thereafter. This method can eliminate the necessity for pretreatments such as centrifugation and electrophoresis, enables the quantitative determination to be conducted in an efficient, simple manner, and can be applied to various automatic analyzers. <IMAGE>
Patent AT-E247718-T1 (AT)
Inventor: DUFF GORDON W
IPC: C07H21/04
Filed: 1997-04-03
Granted: 2003-09-15
Abstract: The present invention relates to methods of predicting the risk of osteoporosis. Specifically, the methods comprise isolating genomic DNA from an individual and determining an allelic pattern for IL-1 receptor antagonist (IL-1ra) in the genomic DNA. The identification of at least one copy of allele 2 indicates increased susceptibility to osteoporosis.
Patent AT-E222562-T1 (AT)
Inventor: TORDINI ANGELO
IPC: B65H75/40
Filed: 1997-05-09
Granted: 2002-09-15
Abstract: An apparatus (1) for carrying cables winding drums (2), where a reticular frame (3) includes structure elements (21), fitted in such a way to define a geometrical solid, supports the winding drum (2), which revolves around a horizontal axis (4) of rotation, within its own overall dimensions. Two wheels (5) mounted on the reticular frame (3) with their spin axis (6) parallel to the drum (2) axis of rotation, contained within the overall volume (7) of the solid, allow, together with a handle (11), to operate the apparatus (1). The handle (11) slides in a guide bar (17) to which it is rigidly connected in the operating position, by the relevant means for rigid connection (19, 20).
Patent AT-E224724-T1 (AT)
Inventor: FASSINA GIORGIO
IPC: A61K38/00
Filed: 1997-12-11
Granted: 2002-10-15
Abstract: The present invention relates to a pharmaceutical composition comprising a biologically effective amount of a peptide of formula (I)where NH-X1-CO and NH-X2-CO which are different from one another, are residues of tyrosine or arginine, in L or D configuration, where the hydroxy group of threonine and the guanidine moiety of arginine may be protected by a group conventionally used in peptide chemistry for protecting the hydroxy group and the guanidine moiety, respectively,n is 2, 3, or 4,R is a group capable of forming a dimeric, trimeric, or tetrameric peptide,and a pharmaceutically acceptable inert carrier.
Patent AT-E215930-T1 (AT)
Inventor: LANNUZEL THIERRY
IPC: C07C407/00
Filed: 1998-07-10
Granted: 2002-04-15
Abstract: Preparation method for an organic solution of dialkyl peroxydicarbonate involves (i) reaction in water between alkyl halogeno-formate and inorganic peroxide; and (ii) separating out peroxydicarbonate by solvent extraction with water-immiscible organic solvent selected from usual chain regulators for halogenated polymers, particularly those for fluorinated polymers. Also claimed are: (1) organic solution of dialkyl peroxydicarbonate; (2) method of preparation for halogenated polymers involving intervention of dialkyl peroxydicarbonate; and (3) polymers obtained in (2).
Patent AT-E216000-T1 (AT)
Inventor: CHOLET VINCENT
IPC: C23D3/00
Filed: 1998-02-27
Granted: 2002-04-15
Abstract: Sheet steel is pickled in acid and then given a coating which protects it against corrosion, serves as a lubricating agent during subsequent shaping and is removed by degreasing before nickel-plating and enamelling of the final article. When applied to specific steel sheet 1 mm thick, the coating will withstand 10 cycles of heat and humidity according to DIN50017 without the steel showing any sign of rust. Its lubricating ability is such that a pressed flat bottomed dish 90 mm in diameter, pickled and then coated may be further pressed to a depth of 25 mm by a punch of diameter 50 mm moving at 1.6 mms/sec without rupture up to a force of 65 kN. The coating can be completely removed by immersion in a bath containing 35 g/l sodium metasilicate, 16 g/l trisodic phosphate and 2 g/l nitriloacetic acid at 60 degrees C for 3 mins, followed by immersion in water for 1 min and spraying therewith for 0.5 min.
Patent AT-E246023-T1 (AT)
Inventor: MANTEL DENIS
IPC: A63C9/00
Filed: 1998-07-13
Granted: 2003-08-15
Abstract: The binding platform (1) has a rigid plate (3) on which the binding is mounted and a flexible section (4) extending asymmetrically with respect to the longitudinal axis of the ski. The flexible section extends to a position above on of the edges of the ski to dampen loads exerted on the edge.
Patent AT-E201619-T1 (AT)
Inventor: KALDENHOFF KURT
IPC: B21D53/10
Filed: 1998-01-23
Granted: 2001-06-15
Abstract: A process is disclosed for manufacturing flat bearing shells. A strip of material (2) is cut into bearing shell sections (26), these sections are bent into a semicircular shape, and the outer and inner faces (88, 58), as well as parting surfaces (52), of the thus obtained bearing shells are calibrated. For the outer sides and parting surfaces to be calibrated by a more simple and economic process, the outer side (8) and parting surfaces (52) of the bearing shell sections (26) bent into a semicircular shape are calibrated by upsetting the parting surfaces (52) in a compression moulding die (40). Also disclosed is a compression moulding die for carrying out the process.
Patent AT-E201351-T1 (AT)
Inventor: FREDL RUEDIGER
IPC: B29B9/16
Filed: 1998-02-17
Granted: 2001-06-15
Abstract: The invention relates to a method for recycling polyethylene terephtalate (PET) flakes, characterized in that the flakes are extruded and granulated under vacuum, after which the granulate is aftercondensed in a solid phase under vacuum. Extrusion is preferably carried out in differentiated vent zones and aftercondensation of the solid phase is dependent on temperature, vacuum and time spent in a tumble dryer. Said dryer ensures the even and careful mixing and constant viscosity of the PET product. Said method is used in particular for making PET beverage bottles.
Patent AT-E484572-T1 (AT)
Inventor: MEHTA NOZAR
IPC: C12N15/09
Filed: 1998-04-15
Granted: 2010-10-15
Abstract: The present invention relates to a method of producing an amidated peptide product by producing a precursor having a C-terminal glycine using genetically engineered host cells and thereafter converting said glycine to an amino group to produce a peptide amide. A method for direct expression of a peptide product into a culture medium is also provided.
Patent AT-E229514-T1 (AT)
Inventor: XUE CHU-BIO
IPC: A61K31/395
Filed: 1998-05-14
Granted: 2002-12-15
Abstract: This invention relates to macrocyclic molecules which inhibit metalloproteinases, including aggrecanase, and the production of tumor necrosis factor (TNF). In particular, the compounds are inhibitors of metalloproteinases involved in tissue degradation and inhibitors of the release of tumor necrosis factor. The present invention also relates to pharmaceutical compositions comprising such compounds and to methods of using these compounds for the treatment of inflammatory diseases.
Patent AT-E226659-T1 (AT)
Inventor: VALLI JUHANI
IPC: B01D29/62
Filed: 1998-05-20
Granted: 2002-11-15
Abstract: In the arrangement, the cross section of a blade rotating close to the surface of a screen cylinder changes in such a way that as the pulp consistency changes in the vertical direction of the screen cylinder, the cross section of the blade also changes in order to operate as efficiently as possible according to the pulp consistency by the blade.
Patent AT-E227994-T1 (AT)
Inventor: STOVEN VERONIQUE
IPC: A61K45/00
Filed: 1998-05-28
Granted: 2002-12-15
Abstract: The invention concerns a novel approach for treating cystic fibrosis using, in particular, anti-cancer chemotherapy. For the treatment of cystic fibrosis it proposes the use of at least one product which when administered to a patient brings about the expression or overexpression of an ABC carrier compound, in particular glutathione carrier. Preferably, the products used are anti-cancer products whose administration brings about the expression of MRP and/or MDR protein. The invention is also applicable to the treatment of rheumatoid polyarthritis or asthma. More specifically, the compounds are selected among cyclophosphamide, aclarubicin, doxorubicin, daunorubicin, epirubicin, idarubicin, zorubicin, pirabucin, colchicine, videsine, vinorelbine, vincristine, binblasine, azithromycin, erythromycin, ifosmamide, N-acetyl cysteine, N-acetyl lysine and/or a CFTR protein fragment comprising the NBF1 domain.
Patent AT-E250442-T1 (AT)
Inventor: SHERWOOD CLIFFORD
IPC: A62B35/00
Filed: 1998-06-18
Granted: 2003-10-15
Abstract: The present invention relates to a fall-prevention system comprising a padded belt (10) having a pair of runners (11) carrying running rings (12) to which is attached a karabiner (14) which is connected by a pair of lanyards (15, 16) to a pair of tensioned wires (18, 19). The running rings (12) enable a user to rotate freely while remaining secure to the tensioned safety wires (18, 19) by means of the lanyards (15, 16) while also being able to move along a walkway (20).
Patent AT-E247430-T1 (AT)
Inventor: BRABRAND KNUT
IPC: A61B6/03
Filed: 1998-06-29
Granted: 2003-09-15
Abstract: A method and an apparatus for assisting percutaneous computed tomography-guided surgical activity inside a human or animal body, such as withdrawal of body tissue or body liquid sample, withdrawal of excess body liquid, insertion or injection, said method for determining insertion depth, transversal insertion angle and craniocaudal insertion angle for a needle-type surgical instrument to be inserted into the human or animal body from an insertion entry point on a skin surface of said body to a target inside said body. From a first tomography image coordinate values of said entry point are determined, and from said first or a second tomography image coordinate values of said target point are determined. Based on said coordinate values values of said insertion depth, transversal insertion angle and craniocaudal insertion angle are calculated. Said calculated values are applied to an instrument insertion guiding apparatus positioned adjacent said body in no physical contact therewith, said apparatus having a laser which provides a laser beam, manipulating adjustment means on said apparatus to let the laser beam assume the values of transversal insertion angle and craniocaudal insertion angle and to let the laser beam point at the entry point. The instrument with a needle pointed end thereof is located at said entry point and a longitudinal axis of the instrument is aligned with said laser beam, the aligning being made by letting a distal end face of said instrument be pointed at by said laser beam.
Patent AT-E406382-T1 (AT)
Inventor: WEISS ANTHONY
IPC: C12N15/09
Filed: 1998-07-17
Granted: 2008-09-15
Abstract: The invention relates to derivatives of tropoelastin and variants of those derivatives. The invention further provides expression products and hybrid molecules of the derivatives and variants of the invention. The invention further provides methods for the production of the derivatives, variants, expression products and hybrid molecules. Further provided are formulations, cross-linked structures and implants comprising the derivatives, variants, expression products and hybrid molecules of the invention. Further provided are uses of the derivatives, variants, expression products and hybrid molecules of the invention.
Patent AT-E322549-T1 (AT)
Inventor: LANGHANS GERHARD
IPC: C12M1/107
Filed: 1998-06-15
Granted: 2006-04-15
Abstract: The invention relates to a method and device for producing bio-gas in a fermentation reactor (2) which is substantially devoid of H2S. According to the invention, a substantial amount of the overall contents of the fermentation reactor passes through an area (5) which is impinged upon by a medium containing an electron acceptor, especially air or a gas or gas mixture containing oxygen. The contact time between the medium containing the electron acceptor and the fermentation medium in said area (5) is regulated in such a way that the formation of H2S in the fermentation medium is suppressed to such an extent that no substantial proportion of H2S can be found in the bio-gas. The area (5) is thus configured as a guide tube which is vertically and centrally arranged in the fermentation reactor. Preferably, the bio-gas (6) acts as a propellant and is fed back into the guide tube in order to circulate the contents of the fermentation reactor in said guide tube.
Patent AT-E204657-T1 (AT)
Inventor: LUTZ BERNHARD
IPC: G06F3/00
Filed: 1998-06-26
Granted: 2001-09-15
Abstract: The invention relates to a device for the display and virtual input of data on a screen (14), comprising an image-generating unit (22) for representing an image mask (26) on said screen, an image-receiving unit (28) for optically receiving the image mask (26) being represented and a data processing unit (20) which is connected with both units (22, 28) by way of signals for controlling the image-generating unit (22) and for linking image elements detected by the image-receiving unit (28) with image coordinates of the image mask (26) represented on the screen (14). The screen is embodied by a section of a table top (14) consisting of a transparent and light-diffusing material. The image-generating unit (22) is positioned below and the image-receiving unit (28) above the table top (14).
Patent AT-E301394-T1 (AT)
Inventor: HSIAO YENKUEN
IPC: A01N25/34
Filed: 1998-09-30
Granted: 2005-08-15
Abstract: This invention is concerning about a porous formed article capable of killing or inhibiting the harmful microbes, on which carries the antimicrobes component having function to retard the harmful microbes. The said component is selected from the combination comprising the Low Temperature Far Infrared Material and/or the Quaternary Ammonium Salt. In the invention, the porous formed article capable of killing or inhibiting the harmful microbes is resulted from the tight bonding and/or sticking together between the antimicrobes component and the porous formed article having high surface area; therefore, even after application for long period of time, the active component on it would not be flown away and ;thus, is able to maintain the long effectiveness of antimicrobes.
Patent AT-E346955-T1 (AT)
Inventor: BERGHOF CORNELIA
IPC: C12N15/09
Filed: 1998-08-12
Granted: 2006-12-15
Abstract: The present invention relates to a nucleic acid molecule or molecules and to a process for the detection of bacteria of the Salmonella genus. The invention relates also to a test kit or test kits for carrying out the mentioned detection processes.
Patent AT-E259234-T1 (AT)
Inventor: HILLS BRIAN ANDREW
IPC: A61K31/66
Filed: 1998-11-26
Granted: 2004-02-15
Abstract: A medicament is disclosed for reducing the risk of cross-healing ("adhesions") after surgery. The medicament is a dry powder comprising a surface active phospholipid which is capable of binding to mesothical membranes, and a spreading agent. The medicament is applied as a dry powder to the surgical wound site.
Patent AT-E218606-T1 (AT)
Inventor: LOTH HELMUT
IPC: C09J133/08
Filed: 1998-10-31
Granted: 2002-06-15
Abstract: This invention relates to a jointing compound of an acrylate/acrylonitrile copolymer containing 2 to 8 carbon atoms in the alcohol component as binder and fatty compounds as plasticizer and also fillers and auxiliaries. Epoxystearic acid methyl ester in particular may be used as the fatty compound while a butyl acrylate/acrylonitrile copolymer in particular may be used as the acrylate/acrylonitrile copolymer. The combination of the two substances results in jointing compounds characterized by a dramatic improvement in elasticity (resilience). Accordingly, they are particularly suitable for substrates with different coefficients of thermal expansion.
Patent AT-E201626-T1 (AT)
Inventor: FEILER NORBERT
IPC: B26B13/24
Filed: 1998-12-05
Granted: 2001-06-15
Abstract: Heated cutting instruments are used in particular in the hairdressing field for cauterising and cutting hair. The previously known heated cutting instruments are fitted with exposed or only inadequately covered heating elements. Such cutting instruments are unsatisfactory or even questionable as regards hygiene and safety. The new heated cutting instrument is meant to improve safety and handling of such scissors. The disclosed heated cutting instrument (1) has at least one blade (2) with a recess (11) for receiving a heating element (12). The heating element (12) is entirely enclosed by the blade (2) and is therefore not accessible from the outside. The energy efficiency, heat distribution and safety of the cutting instrument (1) are thus considerably improved. Moreover, its handling is improved by the complete encapsulation of all current-conducting parts. The invention is useful in the field of hairdressing.
Patent AT-E241854-T1 (AT)
Inventor: LANKUTTIS KLAUS
IPC: H01H3/46
Filed: 1999-03-26
Granted: 2003-06-15
Abstract: A movable contact (44) is mounted at the end of a carrier (43), which is supported in one bearing and has a guide rod (5) attached. The guide rod is located in a second bearing (6). The assembly is subjected to the force of a spring (7). The contacts are enclosed within a vacuum chamber by a bellows. The working connection point of a switch rocker (2) at the guide rod is arranged between the two bearings.
Patent AT-E419327-T1 (AT)
Inventor: BLESSING PETER
IPC: C12C7/14
Filed: 1999-05-17
Granted: 2009-01-15
Abstract: A process and assembly regulate the draining of wort fluid from a lauter tun in a beer brewing process.  The lauter process parameters are determined by constructional data, personal expertise, theoretical analysis and/or dynamic evaluation of the control values, measured dimensions, and preliminary values determined. This information and data is incorporated as a series of equations in a mathematical model linking one or more measured values, one or more lauter tun control values, and one or more output values. The values are detected and evaluated using the model during the course of the lauter process. At pre-determined intervals, a comparison is made between the values predicted based on the preliminary values, and the actual values measured. Using the mathematical model, suitable parameters are then varied as required to optimise the process.